Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158


Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes.

Delfosse V, Grimaldi M, Pons JL, Boulahtouf A, le Maire A, Cavailles V, Labesse G, Bourguet W, Balaguer P.

Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):14930-5. doi: 10.1073/pnas.1203574109. Epub 2012 Aug 27.


In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors.

Molina-Molina JM, Amaya E, Grimaldi M, Sáenz JM, Real M, Fernández MF, Balaguer P, Olea N.

Toxicol Appl Pharmacol. 2013 Oct 1;272(1):127-36. doi: 10.1016/j.taap.2013.05.015. Epub 2013 May 25.


Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor gamma (ERRgamma) with high constitutive activity.

Takayanagi S, Tokunaga T, Liu X, Okada H, Matsushima A, Shimohigashi Y.

Toxicol Lett. 2006 Dec 1;167(2):95-105. Epub 2006 Sep 3.


Bisphenol AF is a full agonist for the estrogen receptor ERalpha but a highly specific antagonist for ERbeta.

Matsushima A, Liu X, Okada H, Shimohigashi M, Shimohigashi Y.

Environ Health Perspect. 2010 Sep;118(9):1267-72. doi: 10.1289/ehp.0901819. Epub 2010 Apr 28.


Characterization of novel ligands of ERα, Erβ, and PPARγ: the case of halogenated bisphenol A and their conjugated metabolites.

Riu A, le Maire A, Grimaldi M, Audebert M, Hillenweck A, Bourguet W, Balaguer P, Zalko D.

Toxicol Sci. 2011 Aug;122(2):372-82. doi: 10.1093/toxsci/kfr132. Epub 2011 May 27.


Computer-aided identification of novel protein targets of bisphenol A.

Montes-Grajales D, Olivero-Verbel J.

Toxicol Lett. 2013 Oct 9;222(3):312-20. doi: 10.1016/j.toxlet.2013.08.010. Epub 2013 Aug 20.


Differential estrogenic actions of endocrine-disrupting chemicals bisphenol A, bisphenol AF, and zearalenone through estrogen receptor α and β in vitro.

Li Y, Burns KA, Arao Y, Luh CJ, Korach KS.

Environ Health Perspect. 2012 Jul;120(7):1029-35. doi: 10.1289/ehp.1104689. Epub 2012 Apr 11. Erratum in: Environ Health Perspect. 2012 Dec;120(12):A455.


Nuclear receptor profiling of bisphenol-A and its halogenated analogues.

Delfosse V, Grimaldi M, le Maire A, Bourguet W, Balaguer P.

Vitam Horm. 2014;94:229-51. doi: 10.1016/B978-0-12-800095-3.00009-2. Review.


Structural evidence for endocrine disruptor bisphenol A binding to human nuclear receptor ERR gamma.

Matsushima A, Kakuta Y, Teramoto T, Koshiba T, Liu X, Okada H, Tokunaga T, Kawabata S, Kimura M, Shimohigashi Y.

J Biochem. 2007 Oct;142(4):517-24. Epub 2007 Aug 30.


Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma.

Okada H, Tokunaga T, Liu X, Takayanagi S, Matsushima A, Shimohigashi Y.

Environ Health Perspect. 2008 Jan;116(1):32-8. doi: 10.1289/ehp.10587.


Peroxisome proliferator-activated receptor γ is a target for halogenated analogs of bisphenol A.

Riu A, Grimaldi M, le Maire A, Bey G, Phillips K, Boulahtouf A, Perdu E, Zalko D, Bourguet W, Balaguer P.

Environ Health Perspect. 2011 Sep;119(9):1227-32. doi: 10.1289/ehp.1003328. Epub 2011 May 11.


3D models of MBP, a biologically active metabolite of bisphenol A, in human estrogen receptor α and estrogen receptor β.

Baker ME, Chandsawangbhuwana C.

PLoS One. 2012;7(10):e46078. doi: 10.1371/journal.pone.0046078. Epub 2012 Oct 4.


Structure-activity relationships of bisphenol A analogs at estrogen receptors (ERs): discovery of an ERα-selective antagonist.

Maruyama K, Nakamura M, Tomoshige S, Sugita K, Makishima M, Hashimoto Y, Ishikawa M.

Bioorg Med Chem Lett. 2013 Jul 15;23(14):4031-6. doi: 10.1016/j.bmcl.2013.05.067. Epub 2013 May 30.


In vitro profiling of endocrine disrupting effects of phenols.

Li J, Ma M, Wang Z.

Toxicol In Vitro. 2010 Feb;24(1):201-7. doi: 10.1016/j.tiv.2009.09.008. Epub 2009 Sep 16.


Low concentrations of bisphenol A induce mouse spermatogonial cell proliferation by G protein-coupled receptor 30 and estrogen receptor-α.

Sheng ZG, Zhu BZ.

Environ Health Perspect. 2011 Dec;119(12):1775-80. doi: 10.1289/ehp.1103781. Epub 2011 Aug 3.


Differential interactions of bisphenol A and 17beta-estradiol with estrogen receptor alpha (ERalpha) and ERbeta.

Hiroi H, Tsutsumi O, Momoeda M, Takai Y, Osuga Y, Taketani Y.

Endocr J. 1999 Dec;46(6):773-8.


Bisphenol-A rapidly promotes dynamic changes in hippocampal dendritic morphology through estrogen receptor-mediated pathway by concomitant phosphorylation of NMDA receptor subunit NR2B.

Xu X, Ye Y, Li T, Chen L, Tian D, Luo Q, Lu M.

Toxicol Appl Pharmacol. 2010 Dec 1;249(2):188-96. doi: 10.1016/j.taap.2010.09.007. Epub 2010 Sep 19.


Xenoestrogens alter estrogen receptor (ER) α intracellular levels.

La Rosa P, Pellegrini M, Totta P, Acconcia F, Marino M.

PLoS One. 2014 Feb 20;9(2):e88961. doi: 10.1371/journal.pone.0088961. eCollection 2014. Erratum in: PLoS One. 2014;9(5):e99379.

Supplemental Content

Support Center